RenovoRx, Inc. (RNXT)
1.07
+0.02
(+2.39%)
USD |
NASDAQ |
Jan 14, 16:00
1.05
-0.02
(-1.87%)
After-Hours: 20:00
RenovoRx EPS Diluted (Quarterly): -0.0795 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| SELLAS Life Sciences Group, Inc. | -0.0626 |
| Dyadic International, Inc. | -0.0573 |
| Scienture Holdings, Inc. | -0.1903 |
| DocGo, Inc. | -0.2839 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.912M |
| Revenue (Quarterly) | 0.266M |
| Total Expenses (Quarterly) | 3.178M |
| Enterprise Value | 28.49M |
| Gross Profit Margin (Quarterly) | 80.08% |
| Profit Margin (Quarterly) | -1.09K% |
| Earnings Yield | -33.22% |
| Normalized Earnings Yield | -33.22 |